Clinical Trials Directory

Trials / Completed

CompletedNCT00150865

Evaluation of Efficacy of Lumbar Plexus Bloc After Hip Surgery

Study of Posterior Lumbar Plexus Block for Pain Relief After Hip Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (planned)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Compare lumbar plexus block with ropivacaine 0.475%, 0.4 ml/kg to saline. Each group randomized, includes 30 patients. block performed preoperatively Surgery under general anesthesia. Postoperative evaluation of pain (VAS) as first endpoint, and also morphine consumption via PCA device. Follow-up : 24h. Expectation : sizeable reduction of pain with block, of duration.

Detailed description

Compare lumbar plexus block (randomized) * ropivacaine 0.475%, 0.4 ml/kg * saline 0.4 ml/kg . Each group includes 30 patients. Block performed preoperatively. Surgery under general anesthesia (sufentanil, propofol, atracurium ; maintenance : sevoflurane and nitrous oxide in O2. Sufentanil added peroperatively as clinically needed. Postoperative evaluation of pain (VAS, by an independant blind observer) as first endpoint, and also morphine consumption via PCA device. Adverse effects (nausea, vomiting, etc) recorded Follow-up : 24h. Expectation : sizeable reduction of pain with block, of duration.

Conditions

Interventions

TypeNameDescription
DRUGropivacaine

Timeline

Start date
2001-09-01
Completion
2002-03-01
First posted
2005-09-08
Last updated
2017-11-01

Source: ClinicalTrials.gov record NCT00150865. Inclusion in this directory is not an endorsement.